{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:50:41Z","timestamp":1791370241293,"version":"4.3.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["2023-1-PL BIO-03-ICR-1"],"award-info":[{"award-number":["2023-1-PL BIO-03-ICR-1"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"DOI":"10.1038\/s41418-026-01811-9","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:30:01Z","timestamp":1786717801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MICAL2 as a key effector of \u03b2-catenin signaling driving melanoma progression and therapeutic resistance"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2341-6848","authenticated-orcid":false,"given":"Pierre","family":"Sohier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8712-895X","authenticated-orcid":false,"given":"J\u00e9r\u00e9my H.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-3245","authenticated-orcid":false,"given":"Zackie","family":"Aktary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1431-4081","authenticated-orcid":false,"given":"Nour","family":"Zidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8321-5574","authenticated-orcid":false,"given":"Lara","family":"Araktingi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-1218","authenticated-orcid":false,"given":"Nisamanee","family":"Charoenchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9538-761X","authenticated-orcid":false,"given":"C\u00e9line","family":"Pisibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Caberia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-8762","authenticated-orcid":false,"given":"Eric","family":"Pasmant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9882-2162","authenticated-orcid":false,"given":"Nicolas","family":"Macagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7368-3664","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-5117","authenticated-orcid":false,"given":"Caroline","family":"Gaudy-Marqueste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5826-7486","authenticated-orcid":false,"given":"Eirikur","family":"Steingrimsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-4908","authenticated-orcid":false,"given":"Robert","family":"Ballotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1645-9396","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2010-6107","authenticated-orcid":false,"given":"Lionel","family":"Larue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"1811_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41572-025-00603-8","volume":"11","author":"A Tasdogan","year":"2025","unstructured":"Tasdogan A, Sullivan RJ, Katalinic A, Lebbe C, Whitaker D, Puig S, et al. Cutaneous melanoma. Nat Rev Dis Primers. 2025;11:23.","journal-title":"Nat Rev Dis Primers"},{"key":"1811_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, et al. Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545:175\u201380.","journal-title":"Nature"},{"key":"1811_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/dermatopathology11010005","volume":"11","author":"C Huang","year":"2024","unstructured":"Huang C, Lau TW-S, Smoller BR. Diagnosing cutaneous melanocytic tumors in the molecular era: updates and review of literature. Dermatopathology. 2024;11:26\u201351.","journal-title":"Dermatopathology"},{"key":"1811_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189195","volume":"1879","author":"A Goyal","year":"2024","unstructured":"Goyal A, Murkute SL, Bhowmik S, Prasad CP, Mohapatra P. Belling the \u201ccat\u201d: Wnt\/\u03b2-catenin signaling and its significance in future cancer therapies. Biochim Biophys Acta Rev Cancer. 2024;1879:189195.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1811_CR5","doi-asserted-by":"crossref","unstructured":"Ruan B, Wang C, Gao X, Zhang Z, Niu Z, Liang J, et al. ARHGAP36 imposes a bifurcate activation of adherens junction and actomyosin to promote entosis. Cell Death Differ. Nature Publishing Group; 2026. p. 1\u201318.","DOI":"10.1038\/s41418-026-01668-y"},{"key":"1811_CR6","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41418-024-01341-2","volume":"31","author":"Y-T Liu","year":"2024","unstructured":"Liu Y-T, Chen L, Li S-J, Wang W-Y, Wang Y-Y, Yang Q-C, et al. Dysregulated Wnt\/\u03b2-catenin signaling confers resistance to cuproptosis in cancer cells. Cell Death Differ. 2024;31:1452\u201366.","journal-title":"Cell Death Differ"},{"key":"1811_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41418-024-01328-z","volume":"32","author":"L Xu","year":"2025","unstructured":"Xu L, Liu Q, Liu H, Fan F, Li P, Yue S, et al. Disrupting CCDC137-mediated LZTS2 and \u03b2-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via \u03b2-catenin and AKT. Cell Death Differ. 2025;32:134\u201348.","journal-title":"Cell Death Differ."},{"key":"1811_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41586-025-09111-x","volume":"643","author":"JH Raymond","year":"2025","unstructured":"Raymond JH, Aktary Z, Pouteaux M, Petit V, Luciani F, Wehbe M, et al. Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin. Nature. 2025;643:801\u20139.","journal-title":"Nature"},{"key":"1811_CR9","doi-asserted-by":"publisher","first-page":"e94748","DOI":"10.1371\/journal.pone.0094748","volume":"9","author":"AJ Chien","year":"2014","unstructured":"Chien AJ, Haydu LE, Biechele TL, Kulikauskas RM, Rizos H, Kefford RF, et al. Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt\/beta-catenin signaling. PLoS ONE. 2014;9:e94748.","journal-title":"PLoS ONE"},{"key":"1811_CR10","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1073\/pnas.0811902106","volume":"106","author":"AJ Chien","year":"2009","unstructured":"Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, et al. Activated Wnt\/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci USA. 2009;106:1193\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1811_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ccr.2011.10.030","volume":"20","author":"WE Damsky","year":"2011","unstructured":"Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE, et al. beta-Catenin signaling controls metastasis in BRAF-activated PTEN-deficient melanomas. Cancer Cell. 2011;20:741\u201354.","journal-title":"Cancer Cell"},{"key":"1811_CR12","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1038\/onc.2012.229","volume":"32","author":"SJ Gallagher","year":"2013","unstructured":"Gallagher SJ, Rambow F, Kumasaka M, Champeval D, Bellacosa A, Delmas V, et al. Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. Oncogene. 2013;32:2230\u20138.","journal-title":"Oncogene"},{"key":"1811_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0002-9440(10)65278-9","volume":"154","author":"DL Rimm","year":"1999","unstructured":"Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER. Frequent nuclear\/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am J Pathol. 1999;154:325\u20139.","journal-title":"Am J Pathol"},{"key":"1811_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/dna.2014.2590","volume":"34","author":"S Xu","year":"2015","unstructured":"Xu S, Yang Z, Zhang J, Jiang Y, Chen Y, Li H, et al. Increased levels of \u03b2-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2. DNA Cell Biol. 2015;34:69\u201377.","journal-title":"DNA Cell Biol"},{"key":"1811_CR15","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1101\/gad.450107","volume":"21","author":"V Delmas","year":"2007","unstructured":"Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M, et al. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes & Development. 2007;21:2923\u201335.","journal-title":"Genes & Development"},{"key":"1811_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41580-023-00688-7","volume":"25","author":"O Camp\u00e0s","year":"2024","unstructured":"Camp\u00e0s O, Noordstra I, Yap AS. Adherens junctions as molecular regulators of emergent tissue mechanics. Nat Rev Mol Cell Biol. 2024;25:252\u201369.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1811_CR17","first-page":"5651","volume":"62","author":"M Takahashi","year":"2002","unstructured":"Takahashi M, Fujita M, Furukawa Y, Hamamoto R, Shimokawa T, Miwa N, et al. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin\/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis. Cancer Res. 2002;62:5651\u20136.","journal-title":"Cancer Res"},{"key":"1811_CR18","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1349-7006.2008.00814.x","volume":"99","author":"Y Torisu","year":"2008","unstructured":"Torisu Y, Watanabe A, Nonaka A, Midorikawa Y, Makuuchi M, Shimamura T, et al. Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin\/TCF. Cancer Sci. 2008;99:1139\u201346.","journal-title":"Cancer Sci"},{"key":"1811_CR19","doi-asserted-by":"publisher","first-page":"14973","DOI":"10.1073\/pnas.261574498","volume":"98","author":"D Yan","year":"2001","unstructured":"Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt\/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci USA. 2001;98:14973\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1811_CR20","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1158\/0008-5472.CAN-08-1053","volume":"68","author":"J Goodall","year":"2008","unstructured":"Goodall J, Carreira S, Denat L, Kobi D, Davidson I, Nuciforo P, et al. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Cancer Res. 2008;68:7788\u201394.","journal-title":"Cancer Res"},{"key":"1811_CR21","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1242\/dev.073064","volume":"139","author":"L Hari","year":"2012","unstructured":"Hari L, Miescher I, Shakhova O, Suter U, Chin L, Taketo M, et al. Temporal control of neural crest lineage generation by Wnt\/beta-catenin signaling. Development. 2012;139:2107\u201317.","journal-title":"Development"},{"key":"1811_CR22","doi-asserted-by":"publisher","first-page":"8914","DOI":"10.1128\/MCB.02299-05","volume":"26","author":"A Schepsky","year":"2006","unstructured":"Schepsky A, Bruser K, Gunnarsson GJ, Goodall J, Hallsson JH, Goding CR, et al. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression. Mol Cell Biol. 2006;26:8914\u201327.","journal-title":"Mol Cell Biol"},{"key":"1811_CR23","doi-asserted-by":"publisher","first-page":"14013","DOI":"10.1074\/jbc.C000113200","volume":"275","author":"K Takeda","year":"2000","unstructured":"Takeda K, Yasumoto K, Takada R, Takada S, Watanabe K, Udono T, et al. Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J Biol Chem. 2000;275:14013\u20136.","journal-title":"J Biol Chem"},{"key":"1811_CR24","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1038\/s41388-020-1267-7","volume":"39","author":"R Uka","year":"2020","unstructured":"Uka R, Britschgi C, Kr\u00e4ttli A, Matter C, Mihic D, Okoniewski MJ, et al. Temporal activation of WNT\/\u03b2-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth. Oncogene. 2020;39:4132\u201354.","journal-title":"Oncogene"},{"key":"1811_CR25","first-page":"03623","volume":"25","author":"L Larue","year":"2025","unstructured":"Larue L. E-Cadherin, MITF, and Phenotypic Plasticity in Melanoma: a crossroads between cell adhesion, differentiation, and hormonal regulation. J Investig Dermatol. 2025;25:03623\u20131.","journal-title":"J Investig Dermatol"},{"key":"1811_CR26","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1101\/gad.329771.119","volume":"33","author":"F Rambow","year":"2019","unstructured":"Rambow F, Marine JC, Goding CR. Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities. Genes Dev. 2019;33:1295\u2013318.","journal-title":"Genes Dev"},{"key":"1811_CR27","unstructured":"Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J, et al. OncoKB: a precision oncology knowledge base. JCO Precis Oncol. 2017;2017:PO.17.00011."},{"key":"1811_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature11019","volume":"485","author":"HX Hao","year":"2012","unstructured":"Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature. 2012;485:195\u2013200.","journal-title":"Nature"},{"key":"1811_CR29","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"EH Jho","year":"2002","unstructured":"Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2.a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172\u201383.","journal-title":"Mol Cell Biol"},{"key":"1811_CR30","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1128\/MCB.22.4.1184-1193.2002","volume":"22","author":"B Lustig","year":"2002","unstructured":"Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, et al. Negative feedback loop of Wnt signaling through upregulation of conductin\/axin2 in colorectal and liver tumors. Mol Cell Biol. 2002;22:1184\u201393.","journal-title":"Mol Cell Biol"},{"key":"1811_CR31","doi-asserted-by":"publisher","first-page":"14973","DOI":"10.1073\/pnas.261574498","volume":"98","author":"D Yan","year":"2001","unstructured":"Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt\/beta-catenin signaling is activated in human colon tumors. Proc Natl Acad Sci USA. 2001;98:14973\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1811_CR32","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nature08875","volume":"464","author":"Y Shimomura","year":"2010","unstructured":"Shimomura Y, Agalliu D, Vonica A, Luria V, Wajid M, Baumer A, et al. APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex. Nature. 2010;464:1043\u20137.","journal-title":"Nature"},{"key":"1811_CR33","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1101\/gad.869201","volume":"15","author":"R Rousset","year":"2001","unstructured":"Rousset R, Mack JA, Wharton KAJ, Axelrod JD, Cadigan KM, Fish MP, et al. Naked cuticle targets dishevelled to antagonize Wnt signal transduction. Genes Dev. 2001;15:658\u201371.","journal-title":"Genes Dev"},{"key":"1811_CR34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S1534-5807(02)00180-6","volume":"2","author":"AJ Gir\u00e1ldez","year":"2002","unstructured":"Gir\u00e1ldez AJ, Copley RR, Cohen SM. HSPG modification by the secreted enzyme Notum shapes the Wingless morphogen gradient. Dev Cell. 2002;2:667\u201376.","journal-title":"Dev Cell"},{"key":"1811_CR35","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/mc.20546","volume":"48","author":"JE Foreman","year":"2009","unstructured":"Foreman JE, Sorg JM, McGinnis KS, Rigas B, Williams JL, Clapper ML, et al. Regulation of peroxisome proliferator-activated receptor-beta\/delta by the APC\/beta-catenin pathway and nonsteroidal antiinflammatory drugs. Mol Carcinog. 2009;48:942\u201352.","journal-title":"Mol Carcinog"},{"key":"1811_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/18884","volume":"398","author":"O Tetsu","year":"1999","unstructured":"Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422\u20136.","journal-title":"Nature"},{"key":"1811_CR37","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1074\/jbc.M605851200","volume":"282","author":"N Fujimura","year":"2007","unstructured":"Fujimura N, Vacik T, Machon O, Vlcek C, Scalabrin S, Speth M, et al. Wnt-mediated down-regulation of Sp1 target genes by a transcriptional repressor Sp5. J Biol Chem. 2007;282:1225\u201337.","journal-title":"J Biol Chem"},{"key":"1811_CR38","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340.","journal-title":"Bioinformatics"},{"key":"1811_CR39","doi-asserted-by":"publisher","first-page":"e92317","DOI":"10.1371\/journal.pone.0092317","volume":"9","author":"K Watanabe","year":"2014","unstructured":"Watanabe K, Biesinger J, Salmans ML, Roberts BS, Arthur WT, Cleary M, et al. Integrative ChIP-seq\/microarray analysis identifies a CTNNB1 target signature enriched in intestinal stem cells and colon cancer. PLoS ONE. 2014;9:e92317.","journal-title":"PLoS ONE"},{"key":"1811_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13577-025-01212-z","volume":"38","author":"R Wang","year":"2025","unstructured":"Wang R, Hou Z, Gao X, Wu B, Hu H, Wu H. The role of MICAL2 in cancer progression: mechanisms, challenges, and therapeutic potential. Hum Cell. 2025;38:89.","journal-title":"Hum Cell"},{"key":"1811_CR41","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1242\/jcs.202028","volume":"130","author":"S Fr\u00e9mont","year":"2017","unstructured":"Fr\u00e9mont S, Romet-Lemonne G, Houdusse A, Echard A. Emerging roles of MICAL family proteins - from actin oxidation to membrane trafficking during cytokinesis. J Cell Sci. 2017;130:1509\u201317.","journal-title":"J Cell Sci"},{"key":"1811_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624324","volume":"12","author":"M Nachef","year":"2021","unstructured":"Nachef M, Ali AK, Almutairi SM, Lee S-H. Targeting SLC1A5 and SLC3A2\/SLC7A5 as a potential strategy to strengthen anti-tumor immunity in the tumor microenvironment. Front Immunol. 2021;12:624324.","journal-title":"Front Immunol"},{"key":"1811_CR43","doi-asserted-by":"publisher","first-page":"e1000993","DOI":"10.1371\/journal.pgen.1000993","volume":"6","author":"N Eriksson","year":"2010","unstructured":"Eriksson N, Macpherson JM, Tung JY, Hon LS, Naughton B, Saxonov S, et al. Web-based, participant-driven studies yield novel genetic associations for common traits. PLoS Genet. 2010;6:e1000993.","journal-title":"PLoS Genet"},{"key":"1811_CR44","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1084\/jem.183.3.1185","volume":"183","author":"PF Robbins","year":"1996","unstructured":"Robbins PF, El-Gamil M, Li YF, Kawakami Y, Loftus D, Appella E, et al. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med. 1996;183:1185\u201392.","journal-title":"J Exp Med"},{"key":"1811_CR45","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.celrep.2015.09.037","volume":"13","author":"F Rambow","year":"2015","unstructured":"Rambow F, Job B, Petit V, Gesbert F, Delmas V, Seberg H, et al. New functional signatures for understanding melanoma biology from tumor cell lineage-specific analysis. Cell Rep. 2015;13:840\u201353.","journal-title":"Cell Rep"},{"key":"1811_CR46","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, et al. Toward minimal residual disease-directed therapy in melanoma. Cell. 2018;174:843\u201355.e19.","journal-title":"Cell"},{"key":"1811_CR47","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-12-3385","volume":"73","author":"H Reuveni","year":"2013","unstructured":"Reuveni H, Flashner-Abramson E, Steiner L, Makedonski K, Song R, Shir A, et al. Therapeutic destruction of insulin receptor substrates for cancer treatment. Cancer Res. 2013;73:4383\u201394.","journal-title":"Cancer Res"},{"key":"1811_CR48","doi-asserted-by":"crossref","unstructured":"Tr\u00f6ster BC, Kappelmann-Fenzl M, Bosserhoff AK, Rachinger N. Emerging role of ARHGAP29 in melanoma cell phenotype switching. Mol Oncol. 2025;20:348\u201368.","DOI":"10.1002\/1878-0261.70114"},{"key":"1811_CR49","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/exd.14661","volume":"31","author":"T Koren","year":"2022","unstructured":"Koren T, Zagairy F, Tatour Y, Belhanes-Peled H, Khayat M, Krausz J, et al. Potential digenic contribution to guttate leukoderma as the predominant feature of epidermolysis bullosa simplex. Exp Dermatol. 2022;31:1927\u201331.","journal-title":"Exp Dermatol"},{"key":"1811_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1124202","volume":"11","author":"S Rajan","year":"2023","unstructured":"Rajan S, Terman JR, Reisler E. MICAL-mediated oxidation of actin and its effects on cytoskeletal and cellular dynamics. Front Cell Dev Biol. 2023;11:1124202.","journal-title":"Front Cell Dev Biol"},{"key":"1811_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2407417","volume":"392","author":"JD Wolchok","year":"2025","unstructured":"Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, et al. Final, 10-year outcomes with nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2025;392:11\u201322.","journal-title":"N Engl J Med"},{"key":"1811_CR52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/cells11030518","volume":"11","author":"A Barreno","year":"2022","unstructured":"Barreno A, Orgaz JL. Cytoskeletal remodelling as an Achilles\u2019 heel for therapy resistance in melanoma. Cells. 2022;11:518.","journal-title":"Cells"},{"key":"1811_CR53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1158\/0008-5472.CAN-24-0744","volume":"85","author":"B Garg","year":"2025","unstructured":"Garg B, Khan S, Courelli AS, Panneerpandian P, Sheik Pran Babu D, Mose ES, et al. MICAL2 promotes pancreatic cancer growth and metastasis. Cancer Res. 2025;85:1049\u201363.","journal-title":"Cancer Res"},{"key":"1811_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00952-x","volume":"20","author":"Q Wang","year":"2022","unstructured":"Wang Q, Qi C, Min P, Wang Y, Ye F, Xia T, et al. MICAL2 contributes to gastric cancer cell migration via Cdc42-dependent activation of E-cadherin\/\u03b2-catenin signaling pathway. Cell Commun Signal. 2022;20:136.","journal-title":"Cell Commun Signal"},{"key":"1811_CR55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2013.12.035","volume":"156","author":"MR Lundquist","year":"2014","unstructured":"Lundquist MR, Storaska AJ, Liu T-C, Larsen SD, Evans T, Neubig RR, et al. Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. Cell. 2014;156:563\u201376.","journal-title":"Cell"},{"key":"1811_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1505000","volume":"16","author":"BM Foda","year":"2025","unstructured":"Foda BM, Baker AE, Joachimiak \u0141, Mazur M, Neubig RR. Mechanistic insights into Rho\/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: implications for the involvement of pirin. Front Pharmacol. 2025;16:1505000.","journal-title":"Front Pharmacol"},{"key":"1811_CR57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1021\/acsptsci.8b00048","volume":"2","author":"EM Lisabeth","year":"2019","unstructured":"Lisabeth EM, Kahl D, Gopallawa I, Haynes SE, Misek SA, Campbell PL, et al. Identification of pirin as a molecular target of the CCG-1423\/CCG-203971 series of antifibrotic and antimetastatic compounds. ACS Pharmacol Transl Sci. 2019;2:92\u2013100.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1811_CR58","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","unstructured":"Cancer Genome Atlas NetworkGenomic classification of cutaneous melanoma. Cell. 2015;161:1681\u201396.","journal-title":"Cell."},{"key":"1811_CR59","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44:e71.","journal-title":"Nucleic Acids Res"},{"key":"1811_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"key":"1811_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15:R29.","journal-title":"Genome Biol"},{"key":"1811_CR62","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"1811_CR63","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York; 2016.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"1811_CR64","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.molcel.2015.04.001","volume":"58","author":"C Estar\u00e1s","year":"2015","unstructured":"Estar\u00e1s C, Benner C, Jones KA. SMADs and YAP compete to control elongation of \u03b2-catenin:LEF-1-recruited RNAPII during hESC differentiation. Mol Cell. 2015;58:780\u201393.","journal-title":"Mol Cell"},{"key":"1811_CR65","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"1811_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3892\/etm.2022.11728","volume":"25","author":"X Zhang","year":"2023","unstructured":"Zhang X, Lu M, Zhu J, Zhang C, Wang M. Altered genome\u2011wide hydroxymethylation analysis for neoadjuvant chemoradiotherapy followed by surgery in esophageal cancer. Exp Ther Med. 2023;25:29.","journal-title":"Exp Ther Med"},{"key":"1811_CR67","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-04-2970","volume":"65","author":"J Ackermann","year":"2005","unstructured":"Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 2005;65:4005\u201311.","journal-title":"Cancer Res"},{"key":"1811_CR68","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1158\/2159-8290.CD-14-0729","volume":"4","author":"CE Burd","year":"2014","unstructured":"Burd CE, Liu W, Huynh MV, Waqas MA, Gillahan JE, Clark KS, et al. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Discov. 2014;4:1418\u201329.","journal-title":"Cancer Discov"},{"key":"1811_CR69","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ccr.2009.02.022","volume":"15","author":"N Dhomen","year":"2009","unstructured":"Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V, et al. Oncogenic BRAF induces melanocyte senescence and melanoma in mice. Cancer Cell. 2009;15:294\u2013303.","journal-title":"Cancer Cell"},{"key":"1811_CR70","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/gene.20182","volume":"44","author":"I Yajima","year":"2006","unstructured":"Yajima I, Belloir E, Bourgeois Y, Kumasaka M, Delmas V, Larue L. Spatiotemporal gene control by the Cre-ERT2 system in melanocytes. Genesis. 2006;44:34\u201343.","journal-title":"Genesis"},{"key":"1811_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"1811_CR72","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1101\/gr.234062.117","volume":"28","author":"Y-J Ho","year":"2018","unstructured":"Ho Y-J, Anaparthy N, Molik D, Mathew G, Aicher T, Patel A, et al. Single-cell RNA-seq analysis identifies markers of resistance to targeted BRAF inhibitors in melanoma cell populations. Genome Res. 2018;28:1353\u201363.","journal-title":"Genome Res"},{"key":"1811_CR73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495\u2013502.","journal-title":"Nat Biotechnol"},{"key":"1811_CR74","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s42003-020-01625-6","volume":"4","author":"N Borcherding","year":"2021","unstructured":"Borcherding N, Vishwakarma A, Voigt AP, Bellizzi A, Kaplan J, Nepple K, et al. Mapping the immune environment in clear cell renal carcinoma by single-cell genomics. Commun Biol. 2021;4:122.","journal-title":"Commun Biol"},{"key":"1811_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2025.101239","volume":"16","author":"CT Flower","year":"2025","unstructured":"Flower CT, Liu C, Chuang H-Y, Ye X, Cheng H, Heath JR, et al. Signaling and transcriptional dynamics underlying early adaptation to oncogenic BRAF inhibition. Cell Syst. 2025;16:101239.","journal-title":"Cell Syst"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01811-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:02:41Z","timestamp":1791367361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01811-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":75,"alternative-id":["1811"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01811-9","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations following good scientific practice. TMA were prepared and stored by the Biological Resources Center of the Assistance Publique des Hopitaux de Marseille (CRB-APHM, certified ISO 20387 and ISO 9001 v2015). The samples were obtained after written consent from the patient according to the collection declared to the French Ministry of Education and Research (declaration number DC-2008-429), whose use for research purposes was authorized (authorization number AC-2018-3105). Animal care and use for this study were performed in accordance with the recommendations of the European Community (2010\/63\/UE) for the care and use of laboratory animals. Experimental procedures were specifically approved by the ethics committee of the Institut Curie CEEA-IC#118 (Authorization #55477-2025040415461498 v2 given by the National Authority) in compliance with international guidelines. Mice were housed in a specific-pathogen-free (SPF) certified animal facility with a 12-h light\/dark cycle in a temperature-and humidity-controlled room (22\u2009\u00b1\u20091\u2009\u00b0C and 60%, respectively) with free access to water and food. Tumors developed in the animals at varying time points, and mice were euthanized when the tumor volume reached the maximum allowable size of 1\u2009cm\u00b3.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}